🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/07/2010 | 5,24 | 5,50 | 5,20 | 5,46 | +5,04% | 5,72% | 132.915 |
| 06/07/2010 | 5,35 | 5,35 | 5,17 | 5,20 | -2,11% | 3,50% | 78.841 |
| 02/07/2010 | 5,24 | 5,39 | 5,20 | 5,32 | +1,43% | 3,57% | 61.528 |
| 01/07/2010 | 5,46 | 5,46 | 5,17 | 5,24 | -4,11% | 5,48% | 104.329 |
| 30/06/2010 | 5,20 | 5,69 | 5,20 | 5,46 | +4,29% | 9,35% | 82.581 |
| 29/06/2010 | 5,69 | 5,69 | 5,13 | 5,24 | -9,09% | 9,87% | 184.238 |
| 28/06/2010 | 5,76 | 5,91 | 5,65 | 5,76 | -3,14% | 4,55% | 47.128 |
| 25/06/2010 | 5,43 | 6,18 | 5,32 | 5,95 | +10,42% | 15,86% | 419.559 |
| 24/06/2010 | 5,35 | 5,54 | 5,24 | 5,39 | +0,00% | 5,59% | 114.134 |
| 23/06/2010 | 5,46 | 5,54 | 5,32 | 5,39 | -0,69% | 4,11% | 69.570 |
| 22/06/2010 | 5,65 | 5,69 | 5,43 | 5,43 | -3,33% | 4,64% | 88.192 |
| 21/06/2010 | 5,76 | 5,80 | 5,61 | 5,61 | -0,66% | 3,25% | 84.745 |
| 18/06/2010 | 5,91 | 5,91 | 5,61 | 5,65 | -3,82% | 5,06% | 201.551 |
| 17/06/2010 | 5,80 | 5,88 | 5,73 | 5,88 | +1,95% | 2,58% | 57.868 |
| 16/06/2010 | 5,95 | 5,95 | 5,65 | 5,76 | -3,14% | 5,03% | 110.687 |
| 15/06/2010 | 6,14 | 6,18 | 5,84 | 5,95 | -1,85% | 5,49% | 197.730 |
| 14/06/2010 | 5,95 | 6,06 | 5,80 | 6,06 | +2,53% | 4,40% | 155.731 |
| 11/06/2010 | 5,84 | 5,91 | 5,84 | 5,91 | +0,00% | 1,28% | 33.610 |
| 10/06/2010 | 5,95 | 6,10 | 5,80 | 5,91 | +1,28% | 5,03% | 97.462 |
| 09/06/2010 | 5,91 | 5,91 | 5,76 | 5,84 | +0,65% | 2,53% | 97.623 |
| 08/06/2010 | 5,84 | 5,95 | 5,73 | 5,80 | -0,64% | 3,84% | 153.487 |
| 07/06/2010 | 5,80 | 5,95 | 5,69 | 5,84 | +0,65% | 4,52% | 186.402 |
| 04/06/2010 | 5,88 | 5,91 | 5,76 | 5,80 | -3,13% | 2,55% | 145.098 |
| 03/06/2010 | 5,99 | 6,18 | 5,91 | 5,99 | +1,91% | 4,37% | 76.143 |
| 02/06/2010 | 5,54 | 5,88 | 5,54 | 5,88 | +6,08% | 6,08% | 359.660 |
| 01/06/2010 | 5,73 | 5,73 | 5,54 | 5,54 | -3,90% | 3,27% | 68.769 |
| 28/05/2010 | 5,91 | 5,91 | 5,54 | 5,76 | +1,99% | 6,33% | 135.427 |
| 27/05/2010 | 5,69 | 5,91 | 5,46 | 5,65 | +1,34% | 7,89% | 104.409 |
| 26/05/2010 | 5,39 | 5,69 | 5,39 | 5,58 | +4,19% | 5,55% | 297.463 |
| 25/05/2010 | 5,39 | 5,50 | 5,35 | 5,35 | -2,72% | 2,78% | 152.285 |